Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 50010303
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 2.60E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 4.40E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 4.50E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 4.50E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 5.50E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 5.80E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 5.90E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 9.40E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 9.90E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.06E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.30E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.33E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Auckland Cancer Society Research Centre
Curated by ChEMBL
Auckland Cancer Society Research Centre
Curated by ChEMBL
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair


































